000212458 001__ 212458
000212458 005__ 20240229154907.0
000212458 0247_ $$2doi$$a10.1007/s00520-022-07485-6
000212458 0247_ $$2pmid$$apmid:36692626
000212458 0247_ $$2ISSN$$a0941-4355
000212458 0247_ $$2ISSN$$a1433-7339
000212458 0247_ $$2altmetric$$aaltmetric:141908397
000212458 037__ $$aDKFZ-2023-00175
000212458 041__ $$aEnglish
000212458 082__ $$a610
000212458 1001_ $$0P:(DE-He78)f42e2297e771e17df08f2cc1171df9e4$$aGoldschmidt, Siri$$b0$$eFirst author$$udkfz
000212458 245__ $$aLong-term effects of exercise interventions on physical activity in breast cancer patients: a systematic review and meta-analysis of randomized controlled trials.
000212458 260__ $$aNew York,NY$$bSpringer$$c2023
000212458 3367_ $$2DRIVER$$aarticle
000212458 3367_ $$2DataCite$$aOutput Types/Journal article
000212458 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1674716555_19106$$xReview Article
000212458 3367_ $$2BibTeX$$aARTICLE
000212458 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000212458 3367_ $$00$$2EndNote$$aJournal Article
000212458 500__ $$a#EA:C110#LA:C110#
000212458 520__ $$aBenefits of exercise interventions for cancer patients are well established. This systematic review aimed to investigate the sustainability of exercise interventions with respect to physical activity behaviour of breast cancer patients in the longer term.The databases Pubmed, Cochrane, Embase, and Web of Science were systematically searched for randomized controlled trials (RCTs) investigating aerobic exercise, resistance exercise, or combined exercise interventions in breast cancer patients and assessing physical activity at least 2 months after the intervention. Random-effect models were used to calculate standardized mean differences (SMD).A total of 27 RCTs with 4120 participants were included in the review, of which 11 RCTs with 1545 participants had appropriate data for the meta-analyses. Physical activity was mainly self-reported, and most exercise interventions were supervised. Exercise interventions tended to show a moderate significant effect up to 6 months for moderate to vigorous physical activity (SMD [95% CI] = 0.39 [0.07, 0.70]) and small, non-significant effects on total physical activity at 6 months (SMD [95% CI] = 0.14 [- 0.00, 0.28]) and up to 60 months after the intervention (SMD = 0.29 [-0.31, 0.90]). Differences between intervention characteristics, such as supervised versus unsupervised, were inconclusive due to the small number of RCTs.The physical activity behaviour in breast cancer patients remained improved for several months beyond the end of exercise interventions, but effects were small to moderate and diminished over time. Future studies should clarify how to maintain a healthy level of physical activity after completion of an exercise intervention.
000212458 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000212458 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000212458 650_7 $$2Other$$aBreast neoplasms
000212458 650_7 $$2Other$$aCancer survivorship
000212458 650_7 $$2Other$$aMaintenance
000212458 650_7 $$2Other$$aTraining
000212458 7001_ $$0P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aSchmidt, Martina$$b1$$udkfz
000212458 7001_ $$0P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aSteindorf, Karen$$b2$$eLast author$$udkfz
000212458 773__ $$0PERI:(DE-600)1463166-0$$a10.1007/s00520-022-07485-6$$gVol. 31, no. 2, p. 130$$n2$$p130$$tSupportive care in cancer$$v31$$x0941-4355$$y2023
000212458 909CO $$ooai:inrepo02.dkfz.de:212458$$pVDB
000212458 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)f42e2297e771e17df08f2cc1171df9e4$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000212458 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)2def8f8594c8f797f5ed4398258c6cac$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000212458 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)a0c2037d9054be26907a05ae520d5756$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000212458 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000212458 9141_ $$y2023
000212458 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-15$$wger
000212458 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2022-11-15$$wger
000212458 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-15
000212458 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-15
000212458 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSUPPORT CARE CANCER : 2022$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000212458 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-21
000212458 9202_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000212458 9201_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000212458 9200_ $$0I:(DE-He78)C110-20160331$$kC110$$lBewegung, Präventionsforschung und Krebs$$x0
000212458 980__ $$ajournal
000212458 980__ $$aVDB
000212458 980__ $$aI:(DE-He78)C110-20160331
000212458 980__ $$aUNRESTRICTED